The choice of diuretic in hypertension: Saving the baby from the bathwater

Heart

Volumn 97, Issue 19, 2011, Pages 1547-1551

  Brown, Morris J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DIURETIC AGENT; EPLERENONE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOSARTAN; NIFEDIPINE; PERINDOPRIL; PLACEBO; RENIN INHIBITOR; SODIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VALSARTAN;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DRUG CHOICE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; GYNECOMASTIA; HEALTH CARE ORGANIZATION; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MEDICAL DECISION MAKING; NATRIURESIS; NOTE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; SIDE EFFECT; SODIUM RETENTION; STROKE; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; MALE; PATIENT SELECTION; RISK ASSESSMENT; SODIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 80052672731     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300710     Document Type: Note

References (45)

1. Messerli FH, Makani H, Benjo A, et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol 2011;57:590-600.
2. NICE. Hypertension (update): full guideline. 2011. http://www.nice.org. uk/nicemedia/live/12167/54727/54727.pdf (accessed 22 Aug 2011).
3. Anon. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990;82:1616-28.
4. Anon. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) 1985;291:97-104.
5. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with once-daily calcium channel blockade or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000;356:366-42.
6. Dluhy RG, Lifton RP. Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1999;84:4341-4.
7. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000;289:119-23. (Pubitemid 30463305)
8. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the b-subunit of the epithelial sodium channel. Cell 1994;79:407-14. (Pubitemid 24346056)
9. Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science 2001;293:1107-12. (Pubitemid 32758085)
10. Burton TJ, Salsbury J, Hood S, et al. Conn's syndrome unmasked by thiazide-induced hypokalaemia. Br J Hosp Med In press.
11. Brown MJ. Renin: friend or foe? Heart 2007;93:1026-33. (Pubitemid 47310975)
12. Calhoun DA, Nishizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002;40:892-6. (Pubitemid 35434912)
13. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? J Renin Angiotensin Aldosterone Syst 2004;5:155-60. (Pubitemid 40352950)
14. Simon DB, Nelson Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996;12:24-30. (Pubitemid 26011315)
15. Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001;37:1458-64. (Pubitemid 34225392)
16. Wilson FH, Kahle KT, Sabath E, et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A 2003;100:680-4. (Pubitemid 36126112)
17. Carlsen JE, Kober L, Torp-Pedersen C, et al. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990;300:975-8. (Pubitemid 20144223)
18. Girvin B, Johnston GD. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients. J Hypertens 1998;16:1049-54. (Pubitemid 28367961)
19. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
20. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-21. (Pubitemid 23086643)
21. Hood SJ, Taylor KP, Ashby MJ, et al. The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Circulation 2007;116:268-75. (Pubitemid 47196562)
22. Murphy MB, Lewis PJ, Kohner E, et al. Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet 1982;2:1293-5. (Pubitemid 13240914)
23. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
24. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906. (Pubitemid 41265663)
25. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35. (Pubitemid 37410190)
26. Zillich AJ, Garg J, Basu S, et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48:219-24. (Pubitemid 44309815)
27. Smith SM, Anderson SD, Wen S, et al. Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study. Pharmacotherapy 2009;29:1157-65.
28. Stears A, Woods S, Watts M, et al. Both amiloride and nebivolol have a more favourable effect on glucose tolerance than hydrochlorothiazide in the treatment of essential hypertension - results of a double blind, placebo controlled, randomised cross over study. J Human Hypertens In press.
29. Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 2000;342:905-12. (Pubitemid 30177050)
30. Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-8. (Pubitemid 43740274)
31. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004;43:4-9. (Pubitemid 38031903)
32. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98. (Pubitemid 351620109)
33. Anon. Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J (Engl) 1995;108:710-17.
34. Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290-300.
35. Dahlof B, Devereux RB, Kjeldsen SE, et al. The losartan intervention for endpoint reduction in hypertension study. Lancet 2002;359:995-1003.
36. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-31. (Pubitemid 38781102)
37. Amery A, Birkenhager W, Brixko R, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986;2:589-92. (Pubitemid 16055585)
38. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7. (Pubitemid 24188137)
39. Anon. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992;304:405-12.
40. Pitt B, Reichek N, Willenbrock R, et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-Left Ventricular Hypertrophy Study. Circulation 2003;108:1831-8. (Pubitemid 37296092)
41. Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11-21.
42. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17. (Pubitemid 29407370)
43. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-28.
44. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Pubitemid 35472129)
45. Du X, Cruickshank K, McNamee R, et al. Case-control study of stroke and the quality of hypertension control in north west England. BMJ 1997;314:272-6. (Pubitemid 27047383)